Related Experiment Videos

Pharmacokinetics of single daily dose gentamicin in children with cancer

S M Shankar1, R K Jew, B M Bickert

  • 1Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, USA.

Insights

A single daily dose of 7 mg/kg gentamicin achieved adequate peak serum concentrations in pediatric cancer patients. However, younger children (under 5) had lower gentamicin levels than older children.

Area of Science:

  • Pharmacology
  • Pediatric Oncology
  • Infectious Diseases

Background:

  • Gentamicin is a crucial antibiotic for treating serious infections in pediatric cancer patients.
  • Optimizing gentamicin dosing is essential to maximize efficacy and minimize toxicity.
  • Single daily dose (SDD) regimens are often preferred for convenience and potentially improved outcomes.

Purpose of the Study:

  • To evaluate the pharmacokinetics of single daily dose (SDD) gentamicin in children with cancer.
  • To determine if a 7 mg/kg SDD of gentamicin achieves therapeutic peak serum concentrations.
  • To compare gentamicin concentrations between different age groups in pediatric cancer patients.

Main Methods:

  • Prospective measurement of serum gentamicin concentrations at various time points (0.5, 8, 16, 24 hours) after SDD.
  • Two dosing regimens were studied: 6 mg/kg and 7 mg/kg, with the latter being the focus for pharmacokinetic analysis.
  • Analysis included peak (0.5-hour) and trough (12-hour) concentrations in 54 pediatric cancer patients during 73 febrile episodes.

Main Results:

  • The mean peak serum gentamicin concentration after a 7 mg/kg SDD was 17.2 +/- 3.9 microg/mL, aiming for 15-20 microg/mL.
  • Children younger than 5 years achieved significantly lower peak concentrations (16.1 microg/mL) compared to older children (18.2 microg/mL; P = 0.02).
  • Therapeutic peak concentrations were achieved in 67% of younger children and 84% of older children.

Conclusions:

  • A single daily dose of 7 mg/kg gentamicin is effective in achieving adequate peak serum concentrations in pediatric cancer patients.
  • Age is a significant factor, with younger children (<5 years) requiring consideration for dose adjustments due to lower achieved concentrations.
  • This dosing strategy supports effective gentamicin therapy in this vulnerable population, with age-specific monitoring recommended.
Abstract

Related Concept Videos